Priyesh N. Patel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Priyesh N. Patel has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
David O. Francis
Division of Otolaryngology, Wisconsin Surgical Outcomes Research, Department of Surgery, University of Wisconsin, Madison, Wisconsin, USA
2 shared publicationsEdward B. Penn
Department of Otolaryngology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
2 shared publicationsAl C. Valmadrid
Vanderbilt University Medical School, Nashville, Tennessee, USA
1 shared publicationAlexandra M. Arambula
Vanderbilt University Medical School, Nashville, TN, USA
1 shared publicationAlicia M. Stafford
School of Medicine, Vanderbilt University, Nashville, Tennessee, USA
1 shared publicationAllison P. Wheeler
Division of Hematology-Oncology, Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA
1 shared publication
Latest Publications
- 17 May 2018
- Published by SAGE Publications in JAMA Facial Plastic Surgery
- Vol. 20 (3) , 196-201
Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis
Importance: The buccinator, despite being a prominent midface muscle, has been previously overlooked as a target in the treatment of facial synkinesis with botulinum toxin. Objective: To evaluate outcomes of patients treated with botulinum toxin to the buccinator muscle in the setting of facial synkinesis. Design, Setting, and Participants: Prospective cohort study of patients who underwent treatment for facial synkinesis with botulinum toxin over multiple treatment cycles during a 1-year period was carried out in a tertiary referral center. Interventions: Botulinum toxin treatment of facial musculature, including treatment cycles with and without buccinator injections. Main Outcomes and Measures: Subjective outcomes were evaluated using the Synkinesis Assessment Questionnaire (SAQ) prior to injection of botulinum toxin and 2 weeks after treatment. Outcomes of SAQ preinjection and postinjection scores were compared in patients who had at least 1 treatment cycle with and without buccinator injections. Subanalysis was performed on SAQ questions specific to buccinator function (facial tightness and lip movement). Results: Of 84 patients who received botulinum toxin injections for facial synkinesis, 33 received injections into the buccinator muscle. Of the 33, 23 met inclusion criteria (19 [82.6%] women; mean [SD] age, 46 [10] years). These patients presented for 82 treatment visits, of which 44 (53.6%) involved buccinator injections and 38 (46.4%) were without buccinator injections. The most common etiology of facial paralysis included vestibular schwannoma (10 [43.5%] participants) and Bell Palsy (9 [39.1%] participants). All patients had improved posttreatment SAQ scores compared with prebotulinum scores regardless of buccinator treatment. Compared with treatment cycles in which the buccinator was not addressed, buccinator injections resulted in lower total postinjection SAQ scores (45.9; 95% CI, 38.8–46.8; vs 42.8; 95% CI, 41.3–50.4; P = .43) and greater differences in prebotox and postbotox injection outcomes (18; 95% CI, 16.2–21.8; vs 19; 95% CI, 14.2–21.8; P = .73). Subanalysis of buccinator-specific scores revealed significantly improved postbotox injection scores with the addition of buccinator injections (5.7; 95% CI, 5.0–6.4; vs 4.1; 95% CI, 3.7–4.6; P = .004) and this corresponded to greater differences between prebotulinum and postbotulinum injection scores (3.3; 95% CI, 2.7–3.9; vs 2.0; 95% CI, 1.4–2.6; P = .02). The duration of botulinum toxin effect was similar both with and without buccinator treatment (66.8; 95% CI, 61.7–69.6; vs 65.7; 95% CI, 62.5–71.1; P = .72). Conclusions and Relevance: The buccinator is a symptomatic muscle in the facial synkinesis population. Treatment with botulinum toxin is safe, effective and significantly improves patient symptoms. Level of Evidence: 3 .
- 17 May 2018
- Published by SAGE Publications in JAMA Facial Plastic Surgery
- Vol. 20 (3) , 196-201
Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis
Importance: The buccinator, despite being a prominent midface muscle, has been previously overlooked as a target in the treatment of facial synkinesis with botulinum toxin. Objective: To evaluate outcomes of patients treated with botulinum toxin to the buccinator muscle in the setting of facial synkinesis. Design, Setting, and Participants: Prospective cohort study of patients who underwent treatment for facial synkinesis with botulinum toxin over multiple treatment cycles during a 1-year period was carried out in a tertiary referral center. Interventions: Botulinum toxin treatment of facial musculature, including treatment cycles with and without buccinator injections. Main Outcomes and Measures: Subjective outcomes were evaluated using the Synkinesis Assessment Questionnaire (SAQ) prior to injection of botulinum toxin and 2 weeks after treatment. Outcomes of SAQ preinjection and postinjection scores were compared in patients who had at least 1 treatment cycle with and without buccinator injections. Subanalysis was performed on SAQ questions specific to buccinator function (facial tightness and lip movement). Results: Of 84 patients who received botulinum toxin injections for facial synkinesis, 33 received injections into the buccinator muscle. Of the 33, 23 met inclusion criteria (19 [82.6%] women; mean [SD] age, 46 [10] years). These patients presented for 82 treatment visits, of which 44 (53.6%) involved buccinator injections and 38 (46.4%) were without buccinator injections. The most common etiology of facial paralysis included vestibular schwannoma (10 [43.5%] participants) and Bell Palsy (9 [39.1%] participants). All patients had improved posttreatment SAQ scores compared with prebotulinum scores regardless of buccinator treatment. Compared with treatment cycles in which the buccinator was not addressed, buccinator injections resulted in lower total postinjection SAQ scores (45.9; 95% CI, 38.8–46.8; vs 42.8; 95% CI, 41.3–50.4; P = .43) and greater differences in prebotox and postbotox injection outcomes (18; 95% CI, 16.2–21.8; vs 19; 95% CI, 14.2–21.8; P = .73). Subanalysis of buccinator-specific scores revealed significantly improved postbotox injection scores with the addition of buccinator injections (5.7; 95% CI, 5.0–6.4; vs 4.1; 95% CI, 3.7–4.6; P = .004) and this corresponded to greater differences between prebotulinum and postbotulinum injection scores (3.3; 95% CI, 2.7–3.9; vs 2.0; 95% CI, 1.4–2.6; P = .02). The duration of botulinum toxin effect was similar both with and without buccinator treatment (66.8; 95% CI, 61.7–69.6; vs 65.7; 95% CI, 62.5–71.1; P = .72). Conclusions and Relevance: The buccinator is a symptomatic muscle in the facial synkinesis population. Treatment with botulinum toxin is safe, effective and significantly improves patient symptoms. Level of Evidence: 3 .
- 17 April 2018
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 159 (2) , 242-248
Immediate Use of Uncuffed Tracheostomy after Free Flap Reconstruction of the Head and Neck
Objective: To determine if immediate postoperative uncuffed tracheostomy placement following oral cavity or oropharyngeal head and neck free flap reconstruction is associated with shorter hospital length of stay and higher inpatient decannulation rates without an increase in respiratory complications, as compared with immediate placement of cuffed tracheostomy.Study Design: Retrospective cohort.Setting: Tertiary referral center.Subjects and Methods: Patients were included if they underwent free flap reconstruction for oral cavity or oropharyngeal squamous cell carcinoma and had an intraoperative tracheostomy placed between 2005 and 2016. In 2012, head and neck surgeons changed from routine placement of cuffed to uncuffed tracheostomy tubes immediately after free flap reconstruction. This study compares length of hospital stay, inpatient decannulation rates, and respiratory complications between patients who had cuffed and uncuffed tracheostomies. Analysis of variance and chi‐square test were used to examine continuous and categorical variables, respectively. Multivariable regression analyses were performed to determine whether cuff status was independently associated with primary outcomes of length of hospital stay, decannulation, and respiratory complications.Results: Of 752 patients who underwent free flap reconstruction, 493 patients met inclusion criteria (cuffed, n = 366; uncuffed, n = 127). Patient variables (ie, age, sex, body mass index, prior chemoradiation) and tumor characteristics (ie, location, stage) did not differ significantly between groups. Adjusted analysis showed that an uncuffed tracheostomy (vs a cuffed tracheostomy) was associated with shorter length of stay (7.7 vs 9.7 days, P <. 001) and did not increase the rate of respiratory complications.Conclusion: Immediate placement of a uncuffed tracheostomy after oral cavity or oropharyngeal free flap reconstruction is associated with shorter hospital stays without an increase in respiratory complications.
- 17 April 2018
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 159 (2) , 242-248
Immediate Use of Uncuffed Tracheostomy after Free Flap Reconstruction of the Head and Neck
Objective: To determine if immediate postoperative uncuffed tracheostomy placement following oral cavity or oropharyngeal head and neck free flap reconstruction is associated with shorter hospital length of stay and higher inpatient decannulation rates without an increase in respiratory complications, as compared with immediate placement of cuffed tracheostomy.Study Design: Retrospective cohort.Setting: Tertiary referral center.Subjects and Methods: Patients were included if they underwent free flap reconstruction for oral cavity or oropharyngeal squamous cell carcinoma and had an intraoperative tracheostomy placed between 2005 and 2016. In 2012, head and neck surgeons changed from routine placement of cuffed to uncuffed tracheostomy tubes immediately after free flap reconstruction. This study compares length of hospital stay, inpatient decannulation rates, and respiratory complications between patients who had cuffed and uncuffed tracheostomies. Analysis of variance and chi‐square test were used to examine continuous and categorical variables, respectively. Multivariable regression analyses were performed to determine whether cuff status was independently associated with primary outcomes of length of hospital stay, decannulation, and respiratory complications.Results: Of 752 patients who underwent free flap reconstruction, 493 patients met inclusion criteria (cuffed, n = 366; uncuffed, n = 127). Patient variables (ie, age, sex, body mass index, prior chemoradiation) and tumor characteristics (ie, location, stage) did not differ significantly between groups. Adjusted analysis showed that an uncuffed tracheostomy (vs a cuffed tracheostomy) was associated with shorter length of stay (7.7 vs 9.7 days, P <. 001) and did not increase the rate of respiratory complications.Conclusion: Immediate placement of a uncuffed tracheostomy after oral cavity or oropharyngeal free flap reconstruction is associated with shorter hospital stays without an increase in respiratory complications.
- 6 February 2018
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 158 (5) , 783-800
Evidence‐Based Use of Perioperative Antibiotics in Otolaryngology
Objective: To identify and clarify current evidence supporting and disputing the effectiveness of perioperative antibiotic use for common otolaryngology procedures.Data Sources: PubMed, Embase (OVID), and CINAHL (EBSCO).Review Methods: English‐language, original research (systematic reviews/meta‐analyses, randomized control trials, prospective or retrospective cohort studies, case‐control studies, or case series) studies that evaluated the role of perioperative antibiotic use in common otolaryngology surgeries were systematically extracted using standardized search criteria by 2 investigators independently.Conclusions: Current evidence does not support routine antibiotic prophylaxis for tonsillectomy, simple septorhinoplasty, endoscopic sinus surgery, clean otologic surgery (tympanostomy with tube placement, tympanoplasty, stapedectomy, and mastoidectomy), and clean head and neck surgeries (eg, thyroidectomy, parathyroidectomy, salivary gland excisions). Antibiotic prophylaxis is recommended for complex septorhinoplasty, skull base surgery (anterior and lateral), clean‐contaminated otologic surgery (cholesteatoma, purulent otorrhea), and clean‐contaminated head and neck surgery (violation of aerodigestive tract, free flaps). In these cases, antibiotic use for 24 to 48 hours postoperatively has shown equal benefit to longer duration of prophylaxis. Despite lack of high‐quality evidence, the US Food and Drug Administration suggests antibiotic prophylaxis for cochlear implantation due to the devastating consequence of infection. Data are inconclusive regarding postoperative prophylaxis for nasal packing/splints after sinonasal surgery.Implications for Practice: Evidence does not support the use of perioperative antibiotics for most otolaryngologic procedures. Antibiotic overuse and variability among providers may be due to lack of formal practice guidelines. This review can help otolaryngologists understand current evidence so they can make informed decisions about perioperative antibiotic usage.
- 6 February 2018
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 158 (5) , 783-800
Evidence‐Based Use of Perioperative Antibiotics in Otolaryngology
Objective: To identify and clarify current evidence supporting and disputing the effectiveness of perioperative antibiotic use for common otolaryngology procedures.Data Sources: PubMed, Embase (OVID), and CINAHL (EBSCO).Review Methods: English‐language, original research (systematic reviews/meta‐analyses, randomized control trials, prospective or retrospective cohort studies, case‐control studies, or case series) studies that evaluated the role of perioperative antibiotic use in common otolaryngology surgeries were systematically extracted using standardized search criteria by 2 investigators independently.Conclusions: Current evidence does not support routine antibiotic prophylaxis for tonsillectomy, simple septorhinoplasty, endoscopic sinus surgery, clean otologic surgery (tympanostomy with tube placement, tympanoplasty, stapedectomy, and mastoidectomy), and clean head and neck surgeries (eg, thyroidectomy, parathyroidectomy, salivary gland excisions). Antibiotic prophylaxis is recommended for complex septorhinoplasty, skull base surgery (anterior and lateral), clean‐contaminated otologic surgery (cholesteatoma, purulent otorrhea), and clean‐contaminated head and neck surgery (violation of aerodigestive tract, free flaps). In these cases, antibiotic use for 24 to 48 hours postoperatively has shown equal benefit to longer duration of prophylaxis. Despite lack of high‐quality evidence, the US Food and Drug Administration suggests antibiotic prophylaxis for cochlear implantation due to the devastating consequence of infection. Data are inconclusive regarding postoperative prophylaxis for nasal packing/splints after sinonasal surgery.Implications for Practice: Evidence does not support the use of perioperative antibiotics for most otolaryngologic procedures. Antibiotic overuse and variability among providers may be due to lack of formal practice guidelines. This review can help otolaryngologists understand current evidence so they can make informed decisions about perioperative antibiotic usage.
- 6 February 2018
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 158 (5) , 952-960
Risk Factors for Intraoperative and Postoperative Cerebrospinal Fluid Leaks in Endoscopic Transsphenoidal Sellar Surgery
Objective: To determine the factors associated with intra‐ and postoperative cerebrospinal fluid (CSF) leaks in setting of endoscopic transsphenoidal sellar surgery.Study Design: Retrospective cohort.Setting: Tertiary referral center.Subjects and Methods: This study included 806 patients who underwent endoscopic transsphenoidal sellar surgery between 2004 and 2016. The associations between CSF leaks (intra‐ and postoperative) and patient demographics, medical history, tumor characteristics, and intraoperative repair techniques were analyzed.Results: In sum, 205 (25.4%) patients had a CSF leak: 188 (23.3%) intraoperative leaks and 38 (4.7%) postoperative leaks. Twenty‐one (2.6%) patients had postoperative leaks after having repair of an intraoperative leak; 55% of patients with a postoperative leak had an intraoperative leak repaired. On multivariate analysis, body mass index (BMI), hydrocephalus, suprasellar extension, and craniopharyngioma significantly predicted intraoperative CSF leaks, while only BMI and hydrocephalus predicted postoperative CSF leaks. Patients having septal flap repairs of CSF leaks had a higher postoperative leak rate relative to other repair techniques (odds ratio, 6.37; P =. 013). Rigid reconstruction did not correlate with leaks.Conclusion: For this large cohort of patients undergoing endoscopic transsphenoidal sellar surgery, BMI and hydrocephalus were identified as predictors of postoperative CSF leaks, including those occurring after repair of intraoperative leak. These variables may put stress on the surgical repair of sellar defects, and consideration of these risk factors may help counsel patients and guide perioperative decision making in regard to repair strategies and CSF diversion techniques.
- 6 February 2018
- Published by Wiley in Otolaryngology–Head and Neck Surgery
- Vol. 158 (5) , 952-960
Risk Factors for Intraoperative and Postoperative Cerebrospinal Fluid Leaks in Endoscopic Transsphenoidal Sellar Surgery
Objective: To determine the factors associated with intra‐ and postoperative cerebrospinal fluid (CSF) leaks in setting of endoscopic transsphenoidal sellar surgery.Study Design: Retrospective cohort.Setting: Tertiary referral center.Subjects and Methods: This study included 806 patients who underwent endoscopic transsphenoidal sellar surgery between 2004 and 2016. The associations between CSF leaks (intra‐ and postoperative) and patient demographics, medical history, tumor characteristics, and intraoperative repair techniques were analyzed.Results: In sum, 205 (25.4%) patients had a CSF leak: 188 (23.3%) intraoperative leaks and 38 (4.7%) postoperative leaks. Twenty‐one (2.6%) patients had postoperative leaks after having repair of an intraoperative leak; 55% of patients with a postoperative leak had an intraoperative leak repaired. On multivariate analysis, body mass index (BMI), hydrocephalus, suprasellar extension, and craniopharyngioma significantly predicted intraoperative CSF leaks, while only BMI and hydrocephalus predicted postoperative CSF leaks. Patients having septal flap repairs of CSF leaks had a higher postoperative leak rate relative to other repair techniques (odds ratio, 6.37; P =. 013). Rigid reconstruction did not correlate with leaks.Conclusion: For this large cohort of patients undergoing endoscopic transsphenoidal sellar surgery, BMI and hydrocephalus were identified as predictors of postoperative CSF leaks, including those occurring after repair of intraoperative leak. These variables may put stress on the surgical repair of sellar defects, and consideration of these risk factors may help counsel patients and guide perioperative decision making in regard to repair strategies and CSF diversion techniques.
- 14 July 2017
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 100, 216-222
Post-tonsillectomy hemorrhagic outcomes in children with bleeding disorders at a single institution
- 14 July 2017
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology
- Vol. 100, 216-222
Post-tonsillectomy hemorrhagic outcomes in children with bleeding disorders at a single institution
- 1 December 2016
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology Extra
- Vol. 14, 20-22
Presentation and management of nasopharyngeal carcinoma, a rare childhood malignancy
- 1 December 2016
- Published by Elsevier in International Journal of Pediatric Otorhinolaryngology Extra
- Vol. 14, 20-22
Presentation and management of nasopharyngeal carcinoma, a rare childhood malignancy